Comparison of collagen gels and mammary extracellular matrix as substrata for study of terminal differentiation in rabbit mammary epithelial cells.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 6705839)

Published in Exp Cell Res on April 01, 1984

Authors

C J Wilde, H R Hasan, R J Mayer

Articles by these authors

(truncated to the top 100)

Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70

Carcinoid tumors. N Engl J Med (1999) 6.44

Gastric carcinoma. N Engl J Med (1995) 5.77

Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol (2003) 5.71

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med (1994) 3.29

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol (1997) 3.04

Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease. J Pathol (1988) 2.96

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res (1998) 2.56

Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol (2001) 2.54

A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol (1991) 2.46

Primary central nervous system lymphoma. Ann Intern Med (1993) 2.36

Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood (1991) 2.35

Survival after postoperative combination treatment of rectal cancer. N Engl J Med (1986) 2.24

Carcinoma of the anal canal. N Engl J Med (2000) 2.22

Chemoprevention of colorectal cancer. N Engl J Med (2000) 1.98

Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol (1999) 1.95

Attitudes and practices of U.S. oncologists regarding euthanasia and physician-assisted suicide. Ann Intern Med (2000) 1.90

Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat Med (2000) 1.79

Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. J Clin Oncol (2002) 1.62

Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry (1989) 1.57

A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin. Neurosci Lett (1988) 1.55

Morphologic and cytochemical characteristics of acute promyelocytic leukemia. Am J Hematol (1989) 1.54

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group. J Clin Oncol (1989) 1.53

Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 1.52

Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol (1990) 1.51

B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest (1984) 1.51

Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. J Clin Oncol (2001) 1.48

The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med (1988) 1.41

Diffuse Lewy body disease. Lancet (1989) 1.40

The abnormal isoform of the prion protein accumulates in late-endosome-like organelles in scrapie-infected mouse brain. J Pathol (1995) 1.40

Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971-1988: predictors for later psychologic distress. Cancer (1997) 1.39

Regulation of enzyme turnover during tissue differention. Studies on the effects of hormones on the turnover of fatty acid synthetase in rabbit mammary gland in organ culture. Biochem J (1975) 1.38

alpha B crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease. J Pathol (1992) 1.38

Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol (1997) 1.36

Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol (1999) 1.36

Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiatry (1989) 1.30

Influence of microenvironment on mammary epithelial cell survival in primary culture. J Cell Physiol (1999) 1.29

Testicular self-examination. N Engl J Med (1980) 1.27

Phosphoenolpyruvate-dependent phosphotransferase system enzyme III and plasmid-encoded sucrose transport in Escherichia coli K-12. J Bacteriol (1982) 1.25

Dementia with beta-amyloid deposition: involvement of alpha B-crystallin supports two main diseases. Lancet (1990) 1.23

Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study. Blood (1997) 1.23

Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood (1994) 1.22

Effect of single amino acid replacements on the folding and stability of dihydrofolate reductase from Escherichia coli. Biochemistry (1987) 1.22

Cardiac ultrastructural changes induced by daunorubicin therapy. Cancer (1973) 1.22

Lactose synthesis in the rat, and the effects of litter size and malnutrition. Biochem J (1979) 1.22

Microangiopathic hemolytic anemia and cancer: a review. Medicine (Baltimore) (1979) 1.21

Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump. J Clin Oncol (1983) 1.21

Developmental changes of the 26 S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death. J Biol Chem (1995) 1.20

Expression of polyubiquitin and heat-shock protein 70 genes increases in the later stages of disease progression in scrapie-infected mouse brain. J Neurochem (1994) 1.19

Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial. J Clin Oncol (1992) 1.19

Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg (1993) 1.19

Surface marker analysis of acute myeloblastic leukemia: identification of differentiation-associated phenotypes. Blood (1983) 1.19

Programmed cell death during mammary tissue involution induced by weaning, litter removal, and milk stasis. J Cell Physiol (1996) 1.18

Regulation of enzyme turnover during tissue differentiation. Interactions of insulin, prolactin and cortisol in controlling the turnover of fatty acid synthetase in rabbit mammary gland in organ culture. Biochem J (1976) 1.16

Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer. Cancer (1978) 1.14

Patterns of failure after surgical cure of large liver tumors. A change in the proximate cause of death and a need for effective systemic adjuvant therapy. Am J Surg (1984) 1.14

Clinical suspicion of autopsy-proven thrombotic and tumor pulmonary embolism in cancer patients. Am Heart J (1987) 1.13

Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow. J Natl Cancer Inst (1993) 1.12

The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin North Am (1994) 1.12

Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancer. Ann Oncol (2007) 1.10

Vectorial secretion by constitutive and regulated secretory pathways in mammary epithelial cells. Epithelial Cell Biol (1995) 1.09

Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro. J Immunol (2000) 1.09

Central nervous system involvement by ovarian carcinoma: a complication of prolonged survivial with metastatic disease. Cancer (1978) 1.09

Relationships between components in primate RNA tumor viruses and in the cytoplasm of human leukemic cells: implications to leukemogenesis. Cold Spring Harb Symp Quant Biol (1975) 1.08

A ubiquitin conjugating enzyme encoded by African swine fever virus. EMBO J (1992) 1.08

Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study. J Clin Oncol (1997) 1.07

Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114. J Clin Oncol (2003) 1.06

Does adjuvant therapy work in colon cancer? N Engl J Med (1990) 1.06

Extensive destruction of newly synthesized casein in mammary explants in organ culture. Biochem J (1982) 1.06

Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins. Neurosci Lett (1996) 1.06

The unique aspects of acute promyelocytic leukemia. J Clin Oncol (1990) 1.05

A putative protein-sequestration site involving intermediate filaments for protein degradation by autophagy. Studies with transplanted Sendai-viral envelope proteins in HTC cells. Biochem J (1987) 1.05

Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B. Ann Oncol (1998) 1.04

Absorption of antisera for studies on specific enzyme turnover. Biochem J (1976) 1.04

The role of enzyme degradation in enzyme turnover during tissue differentiation. Biochim Biophys Acta (1977) 1.04

Oxaliplatin-induced Evan's syndrome. Br J Cancer (2001) 1.04

Ubiquitin in neurodegenerative diseases. Brain Pathol (1993) 1.03

Proteins are secreted by both constitutive and regulated secretory pathways in lactating mouse mammary epithelial cells. J Cell Biol (1992) 1.03

Lactose synthesis and the utilisation of glucose by rat mammary acini. Int J Biochem (1981) 1.03

Ubiquitin is a component of neurofibrillary tangles in a variety of neurodegenerative diseases. Neurosci Lett (1988) 1.03

High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity. Am J Med (1980) 1.02

Purification and immunochemical characterization of monoamine oxidase from rat and human liver. Biochem J (1977) 1.01

Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial. J Clin Oncol (1991) 1.01

Purification and properties of 6-phosphogluconate dehydrogenase from rabbit mammary gland. Biochem J (1975) 1.00

The effect of goat milk fractions on synthesis of milk constituents by rabbit mammary explants and on milk yield in vivo. Evidence for autocrine control of milk secretion. Biochem J (1987) 1.00

Intracellular protein catabolism: state of the art. FEBS Lett (1986) 0.99

Ubiquitin-protein conjugates accumulate in the lysosomal system of fibroblasts treated with cysteine proteinase inhibitors. Biochem J (1989) 0.99

The expression of alpha B-crystallin in epithelial tumours: a useful tumour marker? J Pathol (1994) 0.98

Molecular weight and subunit size of fatty acid synthetase from rabbit mammary gland. Biochem J (1976) 0.98

Immunochemical characterization of casein from rabbit mammary gland. Biochem J (1978) 0.98

Substrate specificities and properties of human phospholipases A2 in a mixed vesicle model. J Biol Chem (1992) 0.98

DNA-metabolizing enzymes in normal human lymphoid cells. VI. Induction of DNA polymerases alpha, beta, and gamma following stimulation with phytohemagglutinin. Blood (1975) 0.98

Glucose metabolism in the mucosa of the small intestine. Changes of hexokinase activity during perfusion of the proximal half of rat small intestine. Biochem J (1970) 0.98

Characterization of two monoclonal antibodies obtained after immunization with human liver mitochondrial membrane preparations. Biochem J (1984) 0.97

Organelle membrane-cell fusion: destruction of transplanted mitochondrial proteins in hepatocyte monolayers. Biochem Biophys Res Commun (1982) 0.97

Inhibition of constitutive protein secretion from lactating mouse mammary epithelial cells by FIL (feedback inhibitor of lactation), a secreted milk protein. J Cell Sci (1993) 0.97

Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: phase I and neuropathological study. Cancer Res (1986) 0.97

Doxorubicin in pregnancy: possible transplacental passage. Cancer Treat Rep (1983) 0.97

Lipogenic enzymes in rat maternal adipose tissue in the perinatal period. Biochem J (1980) 0.97

CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer. Ann Thorac Surg (2001) 0.96